Beauty Health Company (SKIN) News and press releases

New Clinical Study Finds Hydrafacial Clarifying Treatments Improve Acne Skin Concerns In 100% Of Participants

12 Jan 23

Biotech, News, General

Beloved professional skincare treatment Hydrafacial is now clinically reported to improve acne skin concerns, according to a new study published in the peer-reviewed Journal of Clinical and Aesthetic Dermatology (JCAD).

What 6 Analyst Ratings Have To Say About Beauty Health

23 Nov 22

Analyst Ratings

Goldman Sachs Maintains Buy on Beauty Health, Lowers Price Target to $19

23 Nov 22

News, Price Target, Analyst Ratings

Goldman Sachs analyst Amit Hazan maintains Beauty Health (NASDAQ:SKIN) with a Buy and lowers the price target from $22 to $19.

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

10 Nov 22

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers

What 6 Analyst Ratings Have To Say About Beauty Health

9 Nov 22

Analyst Ratings

Analysts have provided the following ratings for Beauty Health (NASDAQ:SKIN) within the last quarter:

Stocks That Hit 52-Week Lows On Wednesday

9 Nov 22

Options

On Wednesday, 283 companies set new 52-week lows.

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session

9 Nov 22

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022

9 Nov 22

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

Upgrades

Where Beauty Health Stands With Analysts

9 Nov 22

Analyst Ratings

Over the past 3 months, 6 analysts have published their opinion on Beauty Health (NASDAQ:SKIN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

JP Morgan Downgrades Beauty Health to Neutral, Lowers Price Target to $11

9 Nov 22

News, Downgrades, Price Target, Analyst Ratings

JP Morgan analyst Allen Gong downgrades Beauty Health (NASDAQ:SKIN) from Overweight to Neutral and lowers the price target from $22 to $11.

DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $32

9 Nov 22

News, Price Target, Analyst Ratings

DA Davidson analyst Linda Bolton Weiser maintains Beauty Health (NASDAQ:SKIN) with a Buy and raises the price target from $31 to $32.

Stocks That Hit 52-Week Lows On Tuesday

8 Nov 22

Options

Tuesday's session saw 184 companies set new 52-week lows.

Update: The Beauty Health Company Q3 Adj. EPS $0.05 Beats $0.02 Estimate

8 Nov 22

Earnings, News

The Beauty Health Company - Class A Common Stock (NASDAQ:SKIN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is a 103.07 percent increase over

BeautyHealth Raised Revenue Guidance To $360M - $365M From $340M - $350M Prior, Vs. $337.42M Estimate

8 Nov 22

News, Guidance

Outlook BeautyHealth increased its fiscal 2022 net sales guidance and now expects net sales in the range of $360.0 million to $365.0 million, up from the previous outlook of $340.0 million to $350.0 million, reflectingOutlook

The Beauty Health Company Q3 Adj. EPS $0.05 Beats $0.02 Estimate, Sales $88.79M Beat $80.55M Estimate

8 Nov 22

Earnings, News, Small Cap

The Beauty Health Company (NASDAQ: SKIN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent. This is a 103.07 percent increase over losses of $(1.63) per share from the same period last year.

Earnings Scheduled For November 8, 2022

8 Nov 22

Earnings

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

BeautyHealth to Participate in Stifel 2022 Healthcare Conference

11 Nov 22

Press Releases

The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that President and Chief Executive Officer Andrew Stanleick and Chief Financial Officer Liyuan Woo will participate in a

Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M

10 Nov 22

Press Releases

Strengthens investor syndicate with participation from biotechnology luminaries Nancy Chang, John Maraganore and Brent Saunders SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Lipidio Pharmaceuticals Inc. (Lipidio), a

BeautyHealth Reports Third Quarter 2022 Financial Results

8 Nov 22

Press Releases

Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop The Beauty

BeautyHealth's Hydrafacial Announces Co-Creation Partnership with Dr. Dennis Gross Skincare for Innovative New Booster

7 Nov 22

Press Releases

The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced a partnership with Dr. Dennis Gross Skincare to co-create a new booster that will bring Dr. Dennis Gross Skincare into the

BeautyHealth's Hydrafacial Rolls Out New Triple AHA Exfoliating Booster with Professional Skincare Brand Glytone

4 Nov 22

Press Releases

The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today unveiled a new exfoliating booster co-created with dermatological skincare brand, Glytone. The Glytone AHA Resurfacing Cellular Booster

BeautyHealth Appoints David Aquino as Executive Vice President Global Operations

2 Nov 22

Press Releases

Joins Executive Committee to strengthen global infrastructure, help fuel company's next phase of profitable growth The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the